# Title
Decreased O
availability O
of O
GDP-L-fucose B-Chemical
in O
a O
patient B-Species
with O
LAD B-Disease
II I-Disease
with O
normal O
GDP-D-mannose B-Chemical
dehydratase I-Gene
and O
FX O
protein O
activities. O

# Abstract
Leukocyte B-Disease
adhesion I-Disease
deficiency I-Disease
type I-Disease
II I-Disease
(LAD B-Disease
II) I-Disease
is O
caused O
by O
a O
disorder O
in O
the O
metabolism O
of O
GDP-L-fucose, B-Chemical
which O
causes O
hypofucosylation O
of O
glycoconjugates. O
This O
study O
analyzes O
a O
newly O
identified O
LAD B-Disease
II I-Disease
patient B-Species
who O
shows O
the O
same O
severe O
hypofucosylation O
of O
glycoconjugates O
as O
the O
other O
described O
patients. B-Species
However, O
in O
vitro O
assays O
of O
cytosolic O
extracts O
from O
leukocytes O
and O
fibroblasts O
of O
the O
patient B-Species
demonstrated O
a O
normal O
GDP-L-fucose B-Chemical
biosynthesis O
from O
GDP-D-mannose. B-Chemical
Analysis O
of O
the O
two O
enzymes O
involved O
in O
the O
pathway, O
GDP-D-mannose B-Chemical
4,6-dehydratase O
and O
FX O
protein, O
revealed O
normal O
numbers O
of O
transcripts O
without O
any O
detectable O
mutations O
within O
the O
coding O
regions O
of O
either O
gene. O
In O
contrast O
to O
previously O
published O
observations O
[Sturla O
et O
al. O
(1998) O
FEBS O
Lett. O
429, O
274-278], O
the O
major O
pathway O
of O
GDP-L-fucose B-Chemical
synthesis O
can O
be O
normal O
in O
LAD B-Disease
II. I-Disease